about
The transcriptome of cerebral ischemiaHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairClinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside.3-Nitropropionic acid-induced ischemia tolerance in the rat brain is mediated by reduced metabolic activity and cerebral blood flowFull steam ahead with remote ischemic conditioning for stroke.Transcriptional expression patterns triggered by chemically distinct neuroprotective molecules.Neurodevelopmental implications of the general anesthesia in neonate and infants.Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage.Ischemic preconditioning attenuates brain edema after experimental intracerebral hemorrhage.Should the STAIR criteria be modified for preconditioning studies?Adaptation and sensitization to proteotoxic stress.Advancing stem cell therapy from bench to bedside: lessons from drug therapiesNovel Cellular Mechanisms for Neuroprotection in Ischemic Preconditioning: A View from Inside Organelles.The hypoxic preconditioning agent deferoxamine induces poly(ADP-ribose) polymerase-1-dependent inhibition of the mitochondrial respiratory chain.Exercise and Cyclic Light Preconditioning Protect Against Light-Induced Retinal Degeneration and Evoke Similar Gene Expression Patterns.The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficitsRepetitive hypoxia extends endogenous neurovascular protection for stroke.Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm.Possible involvement of oxidative stress and inflammatory mediators in the protective effects of the early preconditioning window against transient global ischemia in rats.Protective conditioning of the brain: expressway or roadblock?Bacterial lipopolysaccharide protects the retina from light-induced damage.
P2860
Q27015999-CA52370D-E370-421F-9DBF-47A752C419C5Q28078211-4F9C8390-BC9F-4F51-ABD0-59511555B940Q33357329-1197AC7A-055B-4259-85AA-7395BA9A366DQ34153446-58C40C4A-C167-492E-876F-04848C50DDBDQ34295967-9EAC256F-D087-4BD3-AC79-539974DFA21BQ34417114-6D918AB1-0C0A-447B-97D4-888510F58C3FQ36137464-C66BCEE3-A16F-43EC-AA16-35BE8E93E6C7Q36304010-45AA87D6-8CEC-401C-8D83-B1E66CF03FF4Q36399779-7A39CC5C-5586-407E-83B1-0D0AA835C779Q36634396-FE59662E-389A-4347-8E97-5BECF8B9C2FDQ37651678-7D553FC2-28F4-401D-B0C5-6DF551D6A1F3Q38245564-7AEC6D9D-7AFD-4D8F-8D4A-4646C750A6CBQ38527790-E82DBF5B-F3D6-4CC2-AEFD-D77054AA9E91Q39432184-2A6CA77C-3F97-4F50-BAA7-255779792EF4Q40477445-FA57BB76-3F70-418D-B7E2-61C428E193D8Q41573021-F8F0FE54-95B1-4A9F-ADAB-E7E311FF722DQ41991619-47414F21-58AC-4987-8C67-73605029AA8BQ42620183-AB3DAFE5-34D5-49F1-B179-2DF5589D6E4AQ46503393-0D1CE976-7588-48C0-A7F8-B5D9ADB5E412Q49120809-0CF09EDA-A0F1-4852-A7E3-408A5197AEE5Q50027249-CC174592-28CF-4698-A42D-5A6F72E63171
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacologic preconditioning: translating the promise
@ast
Pharmacologic preconditioning: translating the promise
@en
Pharmacologic preconditioning: translating the promise
@nl
type
label
Pharmacologic preconditioning: translating the promise
@ast
Pharmacologic preconditioning: translating the promise
@en
Pharmacologic preconditioning: translating the promise
@nl
prefLabel
Pharmacologic preconditioning: translating the promise
@ast
Pharmacologic preconditioning: translating the promise
@en
Pharmacologic preconditioning: translating the promise
@nl
P2860
P1476
Pharmacologic preconditioning: translating the promise
@en
P2093
Jeffrey M Gidday
P2860
P2888
P356
10.1007/S12975-010-0011-Y
P577
2010-01-01T00:00:00Z
P5875
P6179
1036139672